The FDA has approved Fabhalta (iptacopan) for the treatment of adults with complement 3 glomerulopathy (C3G), to reduce proteinuria.

The U.S. Food and Drug Administration (FDA) on Wednesday granted accelerated approval for Novartis AG’s (NYSE:NVS) Vanrafia ...

Novartis strengthens its renal disease portfolio with accelerated approval of another drug for immunoglobulin A nephropathy.

Novartis (NYSE:NVS) said on Thursday that it received US FDA's accelerated approval for Vanrafia as a treatment for adults ...

IgAN is a progressive, rare kidney disease in which the immune system attacks the kidneys, often causing glomerular ...

sNDA submission based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGS If approved, FILSPARI could become the first and only FDA-approved treatment for FSGS, a rare kidney ...

Kidneys are one of the very few organs in the ... the amount of sodium in the blood and releasing hormones like renin, which helps regulate vascular resistance and fluid balance.

World Kidney Day 2025 Theme and Significance: Chronic kidney disease (CKD) is estimated to impact around 850 million individuals globally. If not detected and treated promptly, CKD can progress to ...

That’s your kidneys! But what if they started to resign? Sounds alarming, right? That’s exactly why World Kidney Day, observed every second Thursday of March, urges us to give these vital ...

Dwyane Wade is opening up about the changes in his body that he noticed prior to being diagnosed with kidney cancer. The retired NBA pro revealed in an exclusive interview aired March 11 on TODAY ...